- Kokolakis A, Zacharakis G, Krasagakis K, Lasithiotakis K, Favicchio R, Spiliopoulos G, Giannikaki E, Ripoll J, Tosca A. Prehistological evaluation of benign and malignant pigmented skin lesions with optical computed tomography. J Biomed Opt 2012; 17: 066004.
- de Bree E. Sentinel lymph node biopsy and survival in the elderly patients with cutaneous melanoma (invited commentary). Br J Surg 2011; 98: 1407.
- Lasithiotakis KG, Kokolakis A, Giannikaki E, Krasagakis K, Tosca A. Factors associated with the prevalence of atypical nevus in a Mediterranean pigmented skin lesion clinic. Melanoma Res 2011; 21: 469-473.
- Lasithiotakis K, Economou G, Gogas H, Ioannou C, Perisynakis K, Filis D, Kastana O, Bafaloukos D, Decatris M, Catodritis N, Frangia K, Papadakis G, Magarakis M, Tsoutsos D, Chrysos E, Chalkiadakis G, Zoras O. Hyperthermic isolated limb perfusion for recurrent melanomas and soft tissue sarcomas: feasibility and reproducibility in a multi-institutional Hellenic collaborative study. Oncol Rep 2010; 23: 1077-1083.
- Parara S, de Bree E, Takos D, Giannikaki E, Melissas J, Tsiftsis DD. Melanoma of the vulva: a pigmented lesion is also significant in a non-sun-expose area. Arch Gynecol Obstet 2009; 280: 831-834.
- Chalkiadaki G, Nikitovic D, Berdiaki A, Sifaki M, Krasagakis K, Katonis P, Karamanos NK, Tzanakakis GN. Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism. Int J Biochem Cell Biol 2009; 41: 1323-1331.
- Stavroulaki M, Kardassis D, Chatzaki E, Sakellaris G, Lindschau C, Haller H, Tosca A, Krasagakis K. Exposure of normal human melanocytes to a tumor promoting phorbol ester reverses growth suppression by transforming growth factor beta. J Cell Physiol 2008; 214: 363-370.’, 2008; 214: 363-370.
- Nikitovic D, Assouti M, Sifaki M, Katonis P, Krasagakis K, Karamanos NK, Tzanakakis GN. Chondroitin sulfate and heparan sulfate-containing proteoglycans are both partners and targets of basic fibroblast growth factor-mediated proliferation in human metastatic melanoma cell lines. Int J Biochem Cell Biol 2008; 40: 72-83.,’  2008; 40: 72-83.
- de Bree E, Μανιός Α, Τσιφτσής ΔΔ. Η αντιμετώπιση των επιχώριων λεμφαδένων στο μελάνωμα του δέρματος. Ελληνική Χειρουργική 2007; 79: 284-295.
- Karmiris K, Roussomoustakaki M, Tzardi M, Romanos J, Grammatikakis J, Papadakis M, Polychronaki M, Kouroumalis EA. Ileal malignant melanoma causing intussusception: report of a case. Surg Today 2007; 37: 506-509.
- de Bree E, de Bree R, Μανιός Α, Τσιφτσής ΔΔ. Το κακόηθες μελάνωμα του βλεννογόνου της ρινός και των παραρρίνιων κόλπων. Ελληνική Οτορινολαρυγγολογία – Χειρουργική Κεφαλής & Τραχήλου 2007; 28: 136-140.
- de Bree E, Μανιός Α, de Bree R, Τσιφτσής ΔΔ. Το κακόηθες μελάνωμα του δέρματος της ρινός. Ελληνική Χειρουργική Ογκολογία 2006; 6: 70-80. 
- Lasithiotakis K, Leiter U, Kruger-Krasagakis S, Tosca A, Garbe C. Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Wurttemberg). Br J Dermatol 2006; 154: 1123-1127.
- Manousaki AG, Manios AG, Tsompanaki EI, Panayiotides JG, Tsiftsis DD, Kostaki AK, Tosca AD. A simple digital image processing system to aid in melanoma diagnosis in an everyday melanocytic skin lesion unit: a preliminary report. Int J Dermatol 2006; 45: 402-410.
- Lasithiotakis K, Kruger-Krasagakis S, Manousaki A, Ioannidou D, Panagiotides I, Tosca A. The incidence of cutaneous melanoma on Crete, Greece. Int J Dermatol 2006; 45: 397-401.
- Manousaki AG, Manios AG, Tsompanaki EI, Tosca AD. Use of color texture in determining
the nature of melanocytic skin lesions--a qualitative and quantitative approach. Comput Biol Med 2006; 36: 419-427.
- Sifaki M, Assouti M, Nikitovic D, Krasagakis K, Karamanos NK, Tzanakakis GN. Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes. IUBMB Life 2006; 58: 606-610.
- Krasagakis K, Lindschau C, Fimmel S, Eberle J, Quass P, Haller H, Orfanos CE. Proliferation of human melanoma cells is under tight control of protein kinase C alpha. J Cell Physiol 2004; 199: 381-387.
- de Bree E, Μανιός Α, Τσιφτσής ΔΔ. Η τοπική χειρουργική αντιμετώπιση του εντοπισμένου μελανώματος του δέρματος και τα όρια εκτομής’. Ελληνική Χειρουργική 2004; 76: 236-244.
- Lasithiotakis K, Kruger-Krasagakis S, Ioannidou D, Pediaditis I, Tosca A. Epidemiological differences for cutaneous melanoma in a relatively dark-skinned Caucasian population with chronic sun exposure. Eur J Cancer 2004; 40: 2502-2507.
- Krasagakis K, Fimmel S, Genten D, Eberle J, Quas P, Ziegler W, Haller H, Orfanos CE. Lack of protein kinase C (PKC)-beta and low PKC-alpha, -delta, -epsilon, and -zeta isozyme levels in proliferating human melanoma cells. Int J Oncol 2002; 20: 865-871.
- Kontochristopoulos GJ, Stavropoulos PG, Krasagakis K, Goerdt S, Zouboulis CC. Differentiation between merkel cell carcinoma and malignant melanoma: An immunohistochemical study. Dermatology 2000; 201: 123-126.
- Τσαγκατάκης Θ, Κουκουράκη Σ, Ασκοξυλάκης Ι, de Bree E, Στεφανάκη Κ, Τσιφτσής Δ. Η ραδιοϊσοτοπική και χρωματογραφική εντόπιση του λεμφαδένα φρουρού σε καρκίνο του μαστού και σε μελάνωμα του άκρου. Ελληνική Χειρουργική 2000; 72: 476-480.
- de Bree E, Χριστοδουλάκης Μ, Τσιφτσής Δ. Η αντιμετώπιση των νεοπλασμάτων των άκρων με διατήρηση του σκέλους. Μέρος 2: Μελάνωμα. Ελληνική Χειρουργική 1999; 71: 382-392.
- Krasagakis K, Kruger-Krasagakes S, Fimmel S, Eberle J, Tholke D, von der Ohe M, Mansmann U, Orfanos CE. Desensitization of melanoma cells to autocrine TGF-beta isoforms. J Cell Physiol 1999; 178: 179-187.
- Krasagakis K, Tholke D, Farthmann B, Eberle J, Mansmann U, Orfanos CE. Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma. Br J Cancer 1998; 77: 1492-1494.
- Farthmann B, Eberle J, Krasagakis K, Gstottner M, Wang N, Bisson S, Orfanos CE. RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients. J Invest Dermatol 1998; 110: 263-267.
- de Bree E, Sanidas E, Tzardi M, Gaki B, Tsiftsis D. Malignant melanoma of the penis. Eur J Surg Oncol 1997; 23: 277-279.
- de Bree E, Ρωμανός Ι, Ζερβός Κ, Κοκκινάκης Φ, Τσιφτσής Δ. Διεγχειρητιή εντόπιση του ‘λεμφαδένα φρουρού’ σε μελάνωμα του άκρου με τη χορήγηση κυανού του μεθυλενίου ενδοδερμικώς. Ελληνική Χειρουργική 1997; 69: 187-190.
- de Bree E, Ρωμανός Ι, Ζερβός Κ, Κοκκινάκης Φ, Τσιφτσής Δ. Διεγχειρητική εντόπιση του ‘λεμφαδένα φρουρού’ σε μελάνωμα του άκρου με τη χορήγηση κυανού του μεθυλενίου ενδοδερμικώς (επιστολή). Ελληνική Χειρουργική 1997; 69: 485-489.
- Breitbart M, Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, Breitbart EW, Weckbecker J, Panizzon R, Bahmer F, Tilgen W, Guggenmoos-Holzmann I, Orfanos CE. Ultraviolet light exposure, pigmentary traits and the development of melanocytic naevi and
cutaneous melanoma. A case-control study of the German Central Malignant Melanoma Registry. Acta Derm Venereol 1997; 77: 374-378.
- Eberle J, Krasagakis K, Orfanos CE. Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer. 1997; 71: 396-401.
- Morre DJ, Sun E, Geilen C, Wu LY, de Cabo R, Krasagakis K, Orfanos CE, Morre DM. Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines. Eur J Cancer 1996; 32A: 1995-2003.
- Brossart P, Schmier JW, Kruger S, Willhauck M, Scheibenbogen C, Mohler T, Keilholz U. Apolymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 1995; 55: 4065-4068.
- Krasagakis K, Garbe C, Zouboulis CC, Orfanos CE. Growth control of melanoma cells and melanocytes by cytokines. Recent Results Cancer Res 1995; 139: 169-182.
- Kruger-Krasagakes S, Krasagakis K, Garbe C, Diamantstein T. Production of cytokines by human melanoma cells and melanocytes. Recent Results Cancer Res. 1995; 139: 155-168.
- Rieger E, Soyer HP, Garbe C, Buttner P, Kofler R, Weiss J, Stocker U, Kruger S, Roser M, Weckbecker J, et al. Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case-control study of the German Central Malignant-Melanoma Registry. Int J Cancer 1995; 62: 393-397.
- Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, Roser M, Weckbecker J, Panizzon R, Bahmer F, et al. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994; 102: 700-705.
- Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, Roser M, Weckbecker J, Panizzon R, Bahmer F, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society.
J Invest Dermatol 1994; 102: 695-699.
- Kruger-Krasagakes S, Krasagakis K, Garbe C, Schmitt E, Huls C, Blankenstein T, Diamantstein T. Expression of interleukin 10 in human melanoma.
Br J Cancer 1994; 70: 1182-1185.
- Krasagakis K, Garbe C, Schrier PI, Orfanos CE. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro. Anticancer Res 1994; 14: 2565-2571.
- Krasagakis K, Garbe C, Orfanos CE. Cytokines in human melanoma cells: synthesis, autocrine stimulation and regulatory functions--an overview. Melanoma Res 1993; 3: 425-433.
- Krasagakis K, Garbe C, Kruger-Krasagakes S, Orfanos CE. 12-O-tetradecanoylphorbol-13-acetate not only modulates proliferation rates, but also alters antigen
expression and LAK-cell susceptibility of normal human melanocytes in vitro. J Invest Dermatol 1993; 100: 653-659.
- Eberle J, Krasagakis K, Garbe C, Orfanos CE. Proliferation and morphology of melanoma cells and benign human melanocytes under varying culture conditions. Melanoma Res 1993; 3: 107-112.
- Garbe C, Krasagakis K. Effects of interferons and cytokines on melanoma cells. J Invest Dermatol 1993; 100: 239S-244S.
- Garbe C, Weiss J, Kruger S, Garbe E, Buttner P, Bertz J, Hoffmeister H, Guggenmoos-Holzmann I, Jung EG, Orfanos CE. The German melanoma registry and
environmental risk factors implied. Recent Results Cancer Res 1993; 128: 69-89.
- Kruger S, Garbe C, Buttner P, Stadler R, Guggenmoos-Holzmann I, Orfanos CE. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol 1992; 26: 920-926.
- Garbe C, Zouboulis CC, Kruger S, Waibel M, Kreuser ED, Stadler R, Orfanos CE. [Combination of interferon-alpha with cytostatic drugs: a potentially successful therapeutic approach in metastatic melanoma] Hautarzt 1992; 43: 4-10.
- Krasagakis K, Garbe C, Kruger S, Orfanos CE. Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not-alpha or -gamma inhibit proliferation and all interferons significantly modulate the cell phenotype. J Invest Dermatol 1991; 97: 364-372.
- Zouboulis CC, Garbe C, Krasagakis K, Kruger S, Orfanos CE. A fluorometric rapid microassay to identify anti-proliferative compounds for human melanoma cells in vitro. Melanoma Res 1991; 1: 91-95.
- Kyriakis K, Stavropoulos P, Hatziolou E, Dellidis G, Varelzidis A, Tosca A. Coexistence of pemphigus vulgaris, malignant melanoma and low-grade lymphoma.
Dermatologica 1991; 183: 49-52.
- Zouboulis CC, Schroder K, Garbe C, Krasagakis K, Kruger S, Orfanos CE. Cytostatic and cytotoxic effects of recombinant tumor necrosis factor-alpha on sensitive human melanoma cells in vitro may result in selection of cells with enhanced markers of malignancy. J Invest Dermatol
1990; 95 (6 Suppl): 223S-230S.
- Garbe C, Krasagakis K, Zouboulis CC, Schroder K, Kruger S, Stadler R, Orfanos CE. Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype. J Invest Dermatol 1990; 95 (6 Suppl): 231S-237S.
- Garbe C, Kruger S, Stadler R, Guggenmoos-Holzmann I, Orfanos CE. Markers and relative risk in a German population for developing malignant melanoma.
Int J Dermatol 1989; 28: 517-523